Genetic architecture of human fibrotic diseases: disease risk and disease progression
Genetic studies of human diseases have identified multiple genetic risk loci for various fibrotic diseases. This has provided insights into the myriad of biological pathways potentially involved in disease pathogenesis. These discoveries suggest that alterations in immune responses, barrier function...
Main Authors: | Agnès eGardet, Timothy S Zheng, Joanne L Viney |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2013.00159/full |
Similar Items
-
Genome-wide association study identifies new loci associated with risk of HBV infection and disease progression
by: Zheng Zeng, et al.
Published: (2021-03-01) -
Fibrotic Events in the Progression of Cholestatic Liver Disease
by: Hanghang Wu, et al.
Published: (2021-05-01) -
Are mast cells instrumental for fibrotic diseases?
by: Catherine eOvered-Sayer, et al.
Published: (2014-01-01) -
Framework for Interpretation of Genetic Variations in Pancreatitis Patients
by: David eWhitcomb
Published: (2012-12-01) -
Editorial: The Genetic and Environmental Basis for Diseases in Understudied Populations
by: Nicola Mulder, et al.
Published: (2020-09-01)